Stroke Risk Factor Profile in an Urban Population: A Community-Based Descriptive Study in Mojo Sub-District, Surabaya, Indonesia
Downloads
Highlight:
- The stroke risk of the urban population in Mojo sub-district, Surabaya, was high (more than 10% risk for 36.3% of the population) .
- The risk factor for stroke is highly prevalent in Indonesia's urban communities, such as Surabaya.
- The Indonesian version of the Cardiovascular Disease Risk Index chart aids in determining stroke risk factors.
- The development of a stroke-spesific index chart has been done before but requires validation for the Indonesian population
ABSTRACT
Introduction: Stroke is still a major cardiovascular disease in Indonesia. Locally published data regarding stroke risk factors is still rarely reported. This condition complicates the regulation, policy-making, and community empowerment efforts to reduce modifiable stroke risk factors. Thus, a study is necessary to provide an overview of stroke risk factors and risks in cities in Indonesia, such as Surabaya. Objective: This study aimed to describe stroke risk factors in an urban Indonesian community, such as the Mojo sub-district in Surabaya. Methods: This was a descriptive study to describe stroke risk factors like age, gender, history of comorbidities, and history of cardiovascular disease, as well as patient clinical data like neurological symptoms, cardiovascular symptoms, anthropometry, vital signs, simple laboratory values, and cardiovascular risk categorization in the next ten years based on the Cardiovascular Disease Risk Index chart, Indonesian version. Results: In this study, 33 participants were included. Risk factors showed that many participants had histories of active smoking (18.2%), hypertension (45.5%), and diabetes (24.2%). One-third of the participants had a history of dyslipidemia. Based on the risk chart for cardiovascular disease, 36.3% of participants were at >10% risk of developing cardiovascular disease in the next ten years. Conclusion: The risk index of cardiovascular disease in the Mojo sub-district, Surabaya, was still high. A combination of government policies, public awareness improvement, and community empowerment are urgently required to manage these risk factors epidemiologically.
Venketasubramanian N, Yudiarto FL, Tugasworo D. Stroke burden and stroke services in Indonesia. Cerebrovasc Dis Extra. 2022;12(1):53–7.
Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820.
Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208–11.
Chohan S, Venkatesh P, How C. Long-term complications of stroke and secondary prevention: An overview for primary care physicians. Singapore Med J. 2019;60(12):616–20.
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;140(11):e596–646.
Caprio FZ, Sorond FA. Cerebrovascular disease: Primary and secondary stroke prevention. Med Clin North Am. 2019;103(2):295–308.
Pandian JD, Gall SL, Kate MP, Silva GS, Akinyemi RO, Ovbiagele BI, et al. Prevention of stroke: A global perspective. Lancet. 2018;392(10154):1269–78.
Frieden TR, Foti KE. National initiatives to prevent myocardial infarction and stroke. JAMA. 2021;325(14):1391–2.
Owolabi MO, Thrift AG, Mahal A, Ishida M, Martins S, Johnson WD, et al. Primary stroke prevention worldwide: Translating evidence into action. Lancet Public Heal. 2022;7(1):e74–85.
Guzik A, Bushnell C. Stroke epidemiology and risk factor management. Contin Lifelong Learn Neurol. 2017;23(1):15–39.
Cui Q, Naikoo NA. Modifiable and non-modifiable risk factors in ischemic stroke: A meta-analysis. Afr Health Sci. 2019;19(2):2121–9.
Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472–95.
Roy-O'Reilly M, McCullough LD. Age and sex are critical factors in ischemic stroke pathology. Endocrinology. 2018;159(8):3120–31.
Diez-Ascaso O, Martínez-Sánchez P, Fernández-Fournier M, Díez-Tejedor E, Fuentes B. Stroke patients' recognition and knowledge of their own vascular risk factors: A sociocultural study. J Stroke Cerebrovasc Dis. 2015;24(12):2839–44.
Rexrode KM, Madsen TE, Yu AYX, Carcel C, Lichtman JH, Miller EC. The impact of sex and gender on stroke. Circ Res. 2022;130(4):512–28.
Turana Y, Tengkawan J, Chia YC, Nathaniel M, Wang J, Sukonthasarn A, et al. Hypertension and stroke in Asia: A comprehensive review from HOPE Asia. J Clin Hypertens. 2021;23(3):513–21.
Szlachetka WA, Pana TA, Mamas MA, Bettencourt-Silva JH, Metcalf AK, Potter JF, et al. Predicting 10-year stroke mortality: development and validation of a nomogram. Acta Neurol Belg. 2022;122(3):685–93.
Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 12;97(18):1837–47.
Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, et al. 2016 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32(11):1263–82.
González-Diego P, Moreno-Iribas C, Guembe MJ, Viñes JJ, Vila J. Adaptación de la función de riesgo coronario de Framingham-Wilson para la población de Navarra (RICORNA). Rev Española Cardiol. 2009;62(8):875–85.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315–81.
Ishikawa S, Matsumoto M, Kayaba K, Gotoh T, Nago N, Tsutsumi A, et al. Risk charts illustrating the 10-year risk of stroke among residents of Japanese rural communities: The JMS cohort study. J Epidemiol. 2009;19(2):101–6.
Dhimal M, Neupane T, Dhimal ML. Understanding linkages between environmental risk factors and noncommunicable diseases”A review. FASEB BioAdvances. 2021;3(5):287–94.
Budreviciute A, Damiati S, Sabir DK, Onder K, Schuller-Goetzburg P, Plakys G, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Heal. 2020 Nov 26;8.
Cerf ME. Healthy lifestyles and noncommunicable diseases: Nutrition, the life"course, and health promotion. Lifestyle Med. 2021;2(2):e31.
Olatona FA, Onabanjo OO, Ugbaja RN, Nnoaham KE, Adelekan DA. Dietary habits and metabolic risk factors for non-communicable diseases in a university undergraduate population. J Heal Popul Nutr. 2018;37(1):21.
Nianogo RA, Arah OA. Agent-based modeling of noncommunicable diseases: A systematic review. Am J Public Health. 2015;105(3):e20–31.
Allen LN, Smith RW, Simmons-Jones F, Roberts N, Honney R, Currie J. Addressing social determinants of noncommunicable diseases in primary care: A systematic review. Bull World Health Organ 2020;98(11):754-765B.
Jeong NJ, Park E, del Pobil AP. Effects of behavioral risk factors and social-environmental factors on non-communicable diseases in South Korea: A national survey approach. Int J Environ Res Public Health. 2021;18(2):612.
Magnusson RS, McGrady B, Gostin L, Patterson D, Abou Taleb H. Legal capacities required for prevention and control of noncommunicable diseases. Bull World Health Organ. 2018;97(2):108–17.
Copyright (c) 2023 Ilham Ikhtiar, Muhammad Wijdan Rosyich, Muhammad Arief Ardhanu, Dewi Setyaning Bastiana, Dedy Kurniawan, Sita Setyowatie
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
